Loading...

Ibere Pharmaceuticals

IBER-UNNYSE
Financial Services
Shell Companies
$10.16
$-0.21(-2.03%)

Ibere Pharmaceuticals IBER-UN Peers

See (IBER-UN) competitors and their performances in Stock Market.

Peer Comparison Table: Shell Companies Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
IBER-UN$10.16-2.03%031.65$0.32N/A
CCIV$24.25+5.90%44.4BN/AN/AN/A
SYM$38.85+0.00%23.2B-496.00-$0.08N/A
PSACU$17.08+0.35%12B-108.79-$0.16N/A
RTPY$9.91-0.30%11.6BN/AN/AN/A
LVRAW$0.04+0.00%11.5BN/AN/AN/A
CMLFU$13.00-4.55%10.3B-1444.44-$0.01N/A
PSAC$13.78-0.36%9.7BN/AN/AN/A
GRSVU$11.39+3.36%6.8BN/AN/AN/A
APSG$7.39-25.88%6.3B36.95$0.20N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

IBER-UN vs CCIV Comparison

IBER-UN plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, IBER-UN stands at 0. In comparison, CCIV has a market cap of 44.4B. Regarding current trading prices, IBER-UN is priced at $10.16, while CCIV trades at $24.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

IBER-UN currently has a P/E ratio of 31.65, whereas CCIV's P/E ratio is N/A. In terms of profitability, IBER-UN's ROE is +0.02%, compared to CCIV's ROE of -0.69%. Regarding short-term risk, IBER-UN is less volatile compared to CCIV. This indicates potentially lower risk in terms of short-term price fluctuations for IBER-UN.

Stock Price Comparison

Loading...

Frequently Asked Questions

;